Endovascular Today4d
Fluidx Medical Begins Multinational Trial of GPX Embolic Device
Fluidx Medical Technology, Inc. announced that the first patient has been treated in the prospective, multinational, clinical ...
Endovascular Today8d
Patient-Centered Aortic Dissection Care
When I was invited by Endovascular Today to serve as Guest Chief Medical Editor of an edition on aortic dissection (AD), I ...
Endovascular Today6d
IceCure’s ProSense Cryoablation System’s Benefit-Risk Profile for Breast Cancer Indications Reviewed by FDA Panel
IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...
Endovascular Today8d
Radial Access for SFA Intervention Using the IN.PACT™ 018 Drug-Coated Balloon With the SpiderFX™ Filter Wire
Robert L. Minor Jr, MD Interventional Cardiologist and Endovascular Specialist Director of Endovascular Interventions Limb ...
Endovascular Today7d
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...
Endovascular Today8d
Aortic Diseases: Tips for Promoting Medication and Exercise Compliance
Strategies to help counsel aortic disease patients on medications and exercise recommendations to build confidence and ...
Endovascular Today8d
The Next Game Changers for Radial Access in…
Opportunities to improve or optimize radial access for peripheral artery disease and embolization include additions and ...
Endovascular Today9d
Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR
Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...
Endovascular Today5d
Bentley’s BeFlared Bridging Stent for FEVAR Used in First-in-Human Procedure
Bentley InnoMed GmbH announced the first-in-human implantation of the BeFlared stent graft system, which recently received CE ...
Endovascular Today12d
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Endovascular Today12d
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...
Endovascular Today8d
Life After Aortic Dissection: Pregnancy and Family Planning
Dr. Melissa Russo discusses contributing factors, an approach to diagnosing aortic dissection in the pregnant patient, an algorithm for management, common misconceptions, and counseling and ...